SCHEMBL32687964

SCHEMBL32687964

CN(Cc1ccccc1)c1nc(=O)[nH]c(S)c1C#N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAT2A P31153 1/20 0.50
▸ POLB P06746 3/20 0.44
▸ ALDH1A1 P00352 5/20 0.43
▸ LMNA P02545 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ GPR55 Q9Y2T6 1/20 0.43
▸ KDM4E B2RXH2 5/20 0.42
▸ HPGD P15428 2/20 0.42
▸ CRHBP P24387 1/20 0.42
▸ CRHR2 Q13324 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ GRM2 Q14416 1/20 0.41
▸ FABP4 P15090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688399 0.75 KDM4E (0.41) POLBALDH1A1NPSR1GAAKDM4E
SCHEMBL32688468 0.74 MAT2A (0.42) MAT2APOLBALDH1A1LMNANPSR1
SCHEMBL1937758 0.72 MAT2A (0.55) MAT2ALMNAFABP4CSF1RPDE5A
SCHEMBL32688255 0.70 KDR (0.49) MAT2AALDH1A1LMNAFABP4CSF1R
SCHEMBL32688171 0.70 ALDH1A1 (0.57) POLBALDH1A1LMNAKDM4EHPGD
SCHEMBL32687989 0.68 ALDH1A1 (0.44) MAT2APOLBALDH1A1LMNANPSR1
SCHEMBL1224973 0.67 MAT2A (0.49) MAT2APOLBALDH1A1LMNAKDM4E
SCHEMBL2383965 0.67 MAT2A (0.49) MAT2APOLBLMNAFABP4CSF1R
SCHEMBL3288220 0.66 KDM4E (0.51) POLBALDH1A1LMNANPSR1GAA
SCHEMBL16921884 0.65 CSF1R (0.43) MAT2AALDH1A1LMNAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK MAT2A 609/4885POLB 508/4885ALDH1A1 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback